Tirzepatide (Zepbound's active drug) is a dual agonist targeting GLP-1 and GIP
"The peptide capabilities made possible through this acquisition position the company in the coming years to explore exciting advances in peptide innovation, including across areas of consumer need such as preventive health, metabolic optimization, cognitive performance, recovery science, and biological resistances," executives said in a press release
For most other GLP-1 medications, we dont have strong human data on the levels of the drug in breast milk or how this could affect infants
Oral semaglutide (Rybelsus) can increase levothyroxine exposure and requires additional thyroid function monitoring and dose separation
One way to find out how well an antioxidant is working is to measure the amounts of reduced glutathione (GSH) and oxidised glutathione (GSSG) in the blood
...or shop from our GLP-1 a la carte menu